TXG - 10X Genomics - Stock Price & Dividends

10x Genomics Inc. is a life science technology company that develops and sells innovative instruments, consumables, and software solutions for analyzing biological systems globally, with a presence in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

The company's product portfolio includes the Chromium, Chromium Connect, and Chromium Controller instruments, as well as microfluidic chips, slides, reagents, and other consumables. These products enable researchers to gain a deeper understanding of biological systems at the single-cell level.

10x Genomics' single-cell solutions, which run on its Chromium instruments, offer a range of applications, including single-cell gene expression, single-cell immune profiling, single-cell Assay for Transposase Accessible Chromatin (ATAC) solution, and single-cell multiome ATAC + gene expression. These solutions allow researchers to measure gene activity and networks on a cell-by-cell basis, study the immune system, understand the epigenetic state, and simultaneously interrogate both RNA and chromatin accessibility in a single cell.

In addition to its single-cell solutions, the company provides the Visium platform, which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. The Xenium platform is also available for in situ analysis, allowing researchers to analyze biological samples in their native tissue environment.

10x Genomics serves a diverse range of customers, including academic institutions, government agencies, biopharmaceutical companies, biotechnology firms, and other research organizations. By providing cutting-edge solutions, the company aims to accelerate scientific discovery and improve human health.

Founded in 2012, 10x Genomics Inc. was formerly known as 10X Technologies, Inc. and changed its name in November 2014. The company is headquartered in Pleasanton, California, and can be found online at https://www.10xgenomics.com.